
Pediatric Oncologist

No OPD information available
Adult Soft Tissue Sarcoma
Glioma
Gliomatosis Cerebri
Posterior Fossa Tumor
Acute Lymphoblastic Leukemia (ALL)
Bone Tumor
Brain Stem Cancer
Brain Tumor
Diffuse Midline Glioma H3 K27M-Mutant
Embryonal Tumor with Multilayered Rosettes
Ewing Sarcoma
Fibrosarcoma
Grass Allergy
Heart Tumor
Hepatoblastoma
Leukemia
Medulloblastoma
Neuroblastoma
Osteosarcoma
Rhabdoid Tumor
Rhabdomyosarcoma
Tissue Biopsy
Geoffrey B. Mccowage is a doctor who helps people with different types of cancer like soft tissue sarcoma, brain tumors, leukemia, and more. He is a man who is skilled in doing tissue biopsies and treating various cancers in adults and children.
Dr. Mccowage uses special skills and treatments to help his patients fight cancer. He communicates well with patients, making them feel comfortable and trusting in his care. Patients like him because he is kind, knowledgeable, and always explains things clearly.
To stay updated with the latest medical knowledge, Dr. Mccowage reads research papers, attends conferences, and learns from other experts in the field. He works closely with other doctors and medical professionals to provide the best care possible for his patients.
Dr. Mccowage's work has had a positive impact on many patients' lives. He has helped improve their health and quality of life through his treatments and care. One of his notable publications talks about using a new type of medicine to treat a specific type of brain tumor in children.
Currently, Dr. Mccowage is involved in a clinical trial to study a new treatment for children and young adults with certain types of advanced cancers. This trial aims to find better ways to help patients with these difficult-to-treat cancers.
In summary, Dr. Geoffrey B. Mccowage is a caring and skilled doctor who specializes in treating cancer. He uses the latest knowledge and research to provide the best care for his patients, and his work has made a positive impact on many lives.
Enrollment Status: Recruiting
Published: February 14, 2025
Intervention Type: Drug
Study Drug: Oral Repotrectinib (TPX-0005)
Study Phase: Phase 1/Phase 2
